XOMA: XOMA Corporation Stock

by  •  • Comments Off on XOMA: XOMA Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 298.32
Enterprise Value ($M) 269.14
Book Value ($M) 88.72
Book Value / Share 7.63
Price / Book 3.36
NCAV ($M) 23.73
NCAV / Share 2.04
Price / NCAV 12.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.36

Liquidity (mrq)
Quick Ratio 8.68
Current Ratio 8.68

Balance Sheet (mrq) ($M)
Current Assets 169.31
Assets 234.30
Liabilities 145.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4.76
Operating Income -21.89
Net Income -40.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -18.16
Cash from Investing -0.71
Cash from Financing 120.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-09 13G/A Fmr Llc 10.05 -7.35
01-16 13D/A Biotechnology Value Fund L P 31.60 2.92

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 346 6,783 5.10
2024-04-24 225 5,091 4.42
2024-04-23 1,606 5,359 29.97
2024-04-22 980 3,270 29.97

(click for more detail)

Similar Companies
WVE – Wave Life Sciences Ltd. XENE – Xenon Pharmaceuticals Inc.
XNCR – Xencor, Inc.


Financial data and stock pages provided by
Fintel.io